VIRTUAL SYMPOSIUM
Tuesday, 13 October 2020
16:00 – 17:00 CET
10:00 AM – 11:00 AM ET
7:00 AM – 8:00 AM PT
CUTTING-EDGE INSIGHTS
While participating in EADO 2020, please join our faculty as they address pressing questions about unresectable cutaneous squamous cell carcinoma (CSCC). Using real-world patient cases, they will demonstrate how and when to safely incorporate new and emerging immune checkpoint inhibitors into your practice for patients in whom surgery may not be an option.
SYMPOSIUM AGENDA
EDUCATIONAL OBJECTIVES
After completing this activity, the clinician should be better able to:
TARGET AUDIENCE
Oncology, dermatology, and dermato-oncology clinicians who manage patients with cutaneous squamous cell carcinoma (CSCC).
PROVIDER STATEMENT
This educational activity was independently developed by RMEI Medical Education, LLC in collaboration with Advancing Knowledge in Healthcare (AKH) Inc. All faculty and planner conflicts of interest were identified and resolved and AKH has reviewed the content and determined it to be fair, balanced, and without commercial bias.
STATEMENT OF SUPPORT
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme.
FEE STATEMENT
There is no fee for this educational activity.
QUESTIONS?
Please contact Stephanie Kielt at skielt@rmei.com if you have any questions.
Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.